a.almeida
TL2 · Konya
Contributes reviews on supplier material. Based in Konya.
Joined 13 February 2025 · last posted 17h
90 posts, newest first. Showing up to 150.
-
Common supplements people ask about, assessed one at a time Replied, post #107 · Practice › Interactions · 27 Jul 2026 · 3 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #62 · Practice › Administration · 25 Jul 2026 · 9 likes Post #59 describes the usual case. This is about the unusual one. If you have to inject at a different time of day than usual, that is a much smaller perturbation than…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #101 · Nutrition & Training › Protein & intake · 24 Jul 2026 · 14 likes The reason Protein density versus volume keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #66 · Sourcing › Regulatory · 24 Jul 2026 · 2 likes Adding the measurement that post #65 says would settle it. Compounding permissions is one of those subjects where the general answer and the answer for a specific case…
-
Coming back to: Telehealth prescribing models in the US Replied, post #26 · Regional › North America · 23 Jul 2026 · 1 like Post #24 and I disagree about the size of the effect, not about the direction. Telehealth prescribing: widespread in the US and varying in quality. Models without a…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #43 · Compounds › Repair & healing peptides · 20 Jul 2026 · 3 likes On post #39 — agreed on the reasoning, with one qualification. The absence of human trials means there is no established dose, no established interval and no…
-
NHS criteria and how they are applied in practice Replied, post #36 · Regional › UK & Ireland · 20 Jul 2026 · 2 likes Coming back to post #33, because the follow-up matters more than the original answer. MHRA is the regulator. Licensed incretin analogues are prescription-only…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #87 · Evidence › Journal club · 19 Jul 2026 · 19 likes Right, and stated more narrowly than I would have dared to state it.
-
Revisiting: What pooling buys you and what it destroys Replied, post #97 · Evidence › Meta-analyses · 19 Jul 2026 · 1 like On post #95 — agreed on the reasoning, with one qualification. Small correction to my own earlier position on pooling buys. I had the units the wrong way round, which…
-
Pooling trials with different estimands Replied, post #64 · Evidence › Meta-analyses · 2 Jul 2026 · 3 likes The bit of pooling trials with different estimands that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #63 · Analytics › HPLC & UHPLC · 26 Jun 2026 · 10 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
Insurance and replacement policies, compared Replied, post #31 · Sourcing › Logistics · 20 Jun 2026 · 9 likes On post #29 — agreed on the reasoning, with one qualification. Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #114 · Access › Insurance & coverage · 17 Jun 2026 · 7 likes Good question, well framed, and I would like to see it answered properly.
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #52 · Analytics › Method validation · 13 Jun 2026 · 5 likes Post #51 is the version of this I will quote in future. One addition. Precision has two levels worth distinguishing: repeatability within a run and intermediate…
-
Micronutrient adequacy at low total intake Replied, post #34 · Nutrition & Training › Protein & intake · 9 Jun 2026 · 26 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
I have no scientific background — can I still follow the analytics categories? Replied, post #16 · Start Here › Welcome · 9 Jun 2026 · 11 likes Muting is under-used here. A category you mute stops appearing in Latest for you, and you can unmute it in a second. Most long-term members read four or five categories…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #100 · Sourcing › Red flags · 6 Jun 2026 · 0 likes Thank you for the correction. I would rather find out here than later.
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #17 · Practice › Administration · 4 Jun 2026 · 1 like Post #14 is right about the mechanism and I think understates the practical bit. Drawing up with one needle and injecting with another: a reasonable practice if you…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #22 · Practice › Storage & stability · 2 Jun 2026 · 10 likes Understood. Thank you for being specific about the limits of it.
-
Alcohol: what is documented and what is folklore Replied, post #36 · Practice › Interactions · 1 Jun 2026 · 19 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #4 · Start Here › Welcome · 16 May 2026 · 16 likes Marking my place. If it changes for me I will come back and say so.
-
Blind submission and why it changes minds — the long version Replied, post #77 · Sourcing › Independent verification · 15 May 2026 · 22 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #36 · Practice › Dosing & titration · 14 May 2026 · 0 likes Post #35 answers the question as asked. The question underneath it is different. The most useful thing anyone has posted about Micro-titration in this category was a…
-
The best-written scientific paper you have read Replied, post #31 · Lounge › Off topic · 5 May 2026 · 22 likes That is clearer than the version I had in my head. Thank you.
-
Request: show the solution author in the topic list — what changed since Replied, post #41 · Meta › Feature requests · 2 May 2026 · 1 like Modest request: remember my sort preference per category rather than globally. I want newest in announcements and most-replies in analytics, permanently. Two people can…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #94 · Practice › Interactions · 26 Apr 2026 · 19 likes The reason Common supplements is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is…
-
A single out-of-range value on an otherwise normal panel Replied, post #38 · Clinical › Bloodwork · 24 Apr 2026 · 3 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions. The step…
-
Journal club: is percentage weight change the right endpoint? Replied, post #67 · Evidence › Journal club · 14 Apr 2026 · 19 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #38 · Clinical › Bloodwork · 13 Apr 2026 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #85 · Practice › Reconstitution · 7 Apr 2026 · 0 likes A request rather than an answer: could whoever has the primary source for reconstitution volumes post it? I have seen the claim three times this month and each version…
-
A parcel stationary at a customs facility for nine days Replied, post #45 · Sourcing › Logistics · 4 Apr 2026 · 0 likes Post #42 is the version of this I will quote in future. One addition. Tracking stops updating: tracking last updated days ago usually means the package is in transit…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #15 · Access › Pricing · 1 Apr 2026 · 7 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Micro-titration: a disputed topic, argued properly Replied, post #50 · Practice › Dosing & titration · 23 Mar 2026 · 3 likes I have no financial interest in anything named in this thread and I want to say so before I comment on micro-titration, because it is the sort of subject where it…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #16 · Outcomes › Progress reports · 13 Mar 2026 · 6 likes A single scale used throughout beats a more accurate scale introduced halfway through. Consistency beats accuracy for a trend.
-
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #29 · Practice › Dosing & titration · 13 Mar 2026 · 22 likes Where I part company with post #27, and it is a narrow parting. If someone has run splitting a weekly dose properly I would rather read that than my own reconstruction…
-
Second pass at: Identical chromatograms across two different lots Replied, post #41 · Sourcing › Red flags · 4 Mar 2026 · 8 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
Research-use-only status: what it means legally and practically Replied, post #9 · Compounds › Other compounds · 28 Feb 2026 · 27 likes Everything in post #5 holds. The case it does not cover is the one I have. Checked the research-use-only status claim against the primary source this morning. It…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #46 · Analytics › Impurities & related substances · 16 Feb 2026 · 30 likes Picking up post #45: that is the part I would want checked first. Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be…
-
Filter needles: when they help and what they cost you Replied, post #40 · Devices › Syringes & needles · 31 Jan 2026 · 21 likes Adding a data point of agreement rather than a data point.
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #47 · Outcomes › Body composition · 30 Jan 2026 · 16 likes On post #45 — agreed on the reasoning, with one qualification. Report the method with the number, always. A composition figure without the method is not comparable to…
-
Rewriting my first post: a before-and-after, with commentary Replied, post #3 · Start Here › How to Ask · 14 Jan 2026 · 0 likes When you quote a figure from somewhere else, say where from. Not as a formality — the answer frequently depends on whether the number came from a certificate, an…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #15 · Practice › Storage & stability · 9 Jan 2026 · 6 likes The version of Adsorptive losses that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
What to include when your question involves a chromatogram Replied, post #6 · Start Here › How to Ask · 28 Dec 2025 · 0 likes Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method. Everything else follows from method. A chromatogram without…
-
What a good consultation looks like from the other side Replied, post #6 · Clinical › Prescriber conversations · 27 Dec 2025 · 0 likes Noted, and thank you for writing it out rather than summarising it.
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #15 · Practice › Side effects · 26 Dec 2025 · 4 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Request: a diff view for wiki revisions — the long version Replied, post #67 · Meta › Feature requests · 9 Nov 2025 · 6 likes This follows post #66 rather than contradicting it. Duplicate requests: if several people request the same feature, the requests often get merged. Check whether your…
-
Second pass at: Programming during a large energy deficit Replied, post #71 · Nutrition & Training › Resistance training · 7 Nov 2025 · 2 likes Progression during a deficit may mean maintaining rather than adding, and framing that as success rather than stagnation is more accurate. On balance I think that is…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #39 · Start Here › How to Ask · 29 Oct 2025 · 1 like A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #33 · Safety › Adverse events · 18 Oct 2025 · 18 likes Where I part company with post #29, and it is a narrow parting. Nothing here is medical advice, and in this subcategory the phrase is doing more work than in any other…
-
A 40-week log with the measurement method stated Replied, post #22 · Outcomes › Progress reports · 16 Oct 2025 · 0 likes The best progress reports here read as records rather than as arguments, and that difference is visible within a sentence.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #140 · Data & Tools › Calculators · 5 Oct 2025 · 1 like Confirming post #137 from a second method, which matters more than confirming it from a second person. A definition problem is doing most of the work in this titration…
-
A comparison of home results against a laboratory result on the same vial Replied, post #44 · Analytics › Home & field testing · 2 Oct 2025 · 14 likes Thank you — that answers what I came here to find out.
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #64 · Sourcing › Vendor reports · 29 Sep 2025 · 0 likes Two claims get bundled together under vendor documentation pages and they need separating. The descriptive one — this is what was observed — is usually well supported.…
-
Cross-border purchase rules within the EU Replied, post #16 · Regional › European Union · 26 Sep 2025 · 3 likes Confirming post #14 from a second method, which matters more than confirming it from a second person. A methods point on cross-border purchase rules within rather than…
-
A preprint whose numbers changed substantially at publication Replied, post #44 · Evidence › Preprints · 7 Sep 2025 · 1 like What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #47 · Practice › Dosing & titration · 31 Aug 2025 · 0 likes Worth separating two things that post #45 runs together. Holding at a dose that is working is a legitimate position and it is not what the trial protocols did. The…
-
How to read a forest plot, properly, from scratch Replied, post #10 · Evidence › Trials · 30 Jul 2025 · 3 likes Discontinuation handling is the methodological detail that most changes a result and gets the least attention. Read how missing data was imputed before reading the…
-
A field-by-field walk through a certificate of analysis Replied, post #81 · Analytics › COA interpretation · 16 Jul 2025 · 0 likes Sensible. I would want the same detail before I acted on it either.
-
Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #12 · Compounds › Retatrutide · 18 Jun 2025 · 16 likes Following this. I have the same question and no better information than the first post.
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #14 · Start Here › How to Ask · 17 Jun 2025 · 4 likes Adding thanks rather than a view. I do not have a view worth the space.
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #104 · Compounds › Cagrilintide & amylin analogues · 15 Jun 2025 · 13 likes An honest declaration on CagriSema phase 2 paper: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #45 · Pharmacology › Pharmacokinetics · 14 Jun 2025 · 28 likes My experience of Clearance pathways contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly…
-
Follow-up: How much fluid is actually needed, and how you would know Replied, post #18 · Nutrition & Training › Hydration & electrolytes · 31 May 2025 · 5 likes Cramping is the symptom most confidently attributed to electrolytes and has the weakest evidence linking it to them.
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #9 · Compounds › Semaglutide · 28 May 2025 · 0 likes Where I part company with post #5, and it is a narrow parting. The mass figure differs between sources because of how the different entities report it. The monoisotopic…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #63 · Wellbeing › Mental health · 18 May 2025 · 12 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #82 · Clinical › Comorbidities · 12 May 2025 · 27 likes Obstructive sleep apnoea was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
About the Datasets category Replied, post #6 · Data & Tools › Datasets · 8 May 2025 · 5 likes Coming back to post #4, because the follow-up matters more than the original answer. Limitations of datasets: all community-collected data has limitations. The…
-
Reading a trial's population section before its results — does this still hold? Replied, post #65 · Evidence › Trials · 3 May 2025 · 11 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
Reading order for a first week here, and what to skip until later Replied, post #79 · Start Here › Welcome · 12 Apr 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #12 · Practice › Interactions · 11 Mar 2025 · 21 likes Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the…
-
Revisiting: Oral versus injected administration claims for BPC-157 Replied, post #2 · Compounds › Repair & healing peptides · 3 Mar 2025 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Consistent declarations and why they matter more than clever ones Replied, post #113 · Sourcing › Logistics · 2 Mar 2025 · 3 likes Post #111 describes the usual case. This is about the unusual one. Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by…
-
Consistent declarations and why they matter more than clever ones Replied, post #90 · Sourcing › Logistics · 26 Feb 2025 · 1 like Taking post #87 at face value and following it one step further. Practical experience of consistent declarations, offered as one case with the conditions stated, not as…
-
A promotion I argued against, and why I lost Replied, post #97 · Documentation › Doc review · 14 Feb 2025 · 7 likes Understood, and I withdraw the assumption I opened with.
-
Validating a method you did not develop — does this still hold? Started this topic · Analytics › Method validation · 10 Feb 2025 · 0 likes Validating a method you did not develop — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Validating a…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #37 · Clinical › Bloodwork · 30 Jan 2025 · 20 likes Post #36 is right about the mechanism and I think understates the practical bit. Summarising the Lipid changes during rapid weight thread so far, since it is long and…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #38 · Compounds › Secretagogues & GH axis · 18 Jan 2025 · 1 like Building on post #37 rather than restating it. Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible.…
-
Reading a supplementary appendix and finding the interesting part Replied, post #70 · Evidence › Trials · 18 Jan 2025 · 16 likes Composite endpoints should be read component by component. A composite driven entirely by its softest component is a different finding from one where the components…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #147 · Clinical › Prescriber conversations · 14 Jan 2025 · 0 likes Sensible. I would want the same detail before I acted on it either.
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #86 · Evidence › Journal club · 8 Jan 2025 · 0 likes Post #83 answers the question as asked. The question underneath it is different. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #35 · Compounds › Other compounds · 7 Dec 2024 · 19 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
What a seizure notice actually says Replied, post #12 · Sourcing › Logistics · 30 Nov 2024 · 14 likes Post #8 put the caveat in the right place and I want to underline it. If you are new and reading this thread for the answer to seizure notice: the answer is…
-
When to suspect the method rather than the sample Replied, post #39 · Analytics › Method validation · 20 Nov 2024 · 1 like The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number.…
-
EMA product information as a primary source — does this still hold? Replied, post #119 · Regional › European Union · 18 Nov 2024 · 13 likes Adding what did not work for me on EMA product information, since the failures never get written up and they are half the useful information.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #80 · Compounds › Repair & healing peptides · 17 Nov 2024 · 7 likes Checked the reading a preclinical wound-healing model claim against the primary source this morning. It survives, with a narrower scope than the version quoted here.…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #3 · Sourcing › Regulatory · 8 Oct 2024 · 0 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #69 · Analytics › COA interpretation · 29 Sep 2024 · 11 likes On post #65 — agreed on the reasoning, with one qualification. Reading back through the field-by-field walk through a certificate threads from last year, the same three…
-
Progressive overload when the scale is falling — one year on Replied, post #89 · Nutrition & Training › Resistance training · 25 Sep 2024 · 11 likes Worth separating two things that post #87 runs together. The reports here that state the programme, the load and the timeframe are useful. The ones that state an…
-
Priming a pen and whether the primed volume is wasted — one year on Replied, post #3 · marked as the solution · Devices › Pens & autoinjectors · 2 Sep 2024 · 11 likes Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is empty and cannot deliver more. Noting the counter before injection…
-
Over-dilution: when your dose falls below one readable graduation Replied, post #2 · Practice › Reconstitution · 11 Aug 2024 · 3 likes Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only the volume drawn differs. This confuses more…